Cargando…
Targeting Oncogenic Gα(q/11) in Uveal Melanoma
SIMPLE SUMMARY: Uveal melanoma is a deadly form of eye cancer with a high rate of metastasis. Once metastasis occurs, patients are often left with a short survival time, since there is no FDA standard of care for the metastatic disease. Uveal melanoma develops from mutations mainly in proteins invol...
Autores principales: | Lapadula, Dominic, Benovic, Jeffrey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699590/ https://www.ncbi.nlm.nih.gov/pubmed/34944815 http://dx.doi.org/10.3390/cancers13246195 |
Ejemplares similares
-
Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma
por: Ge, Yang, et al.
Publicado: (2022) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021) -
Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese
por: Xu, Xiaolin, et al.
Publicado: (2014) -
Functional characterization of uveal melanoma oncogenes
por: Ma, Jiafang, et al.
Publicado: (2020) -
Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
por: Koopmans, A E, et al.
Publicado: (2013)